Rx Name [CIPROFLOXACIN, 081218]
|
|
CIPLOXIN 200MG INJ (UNI/AHI) CIPROFLOXACIN
|
|
|
|
|
|
081218
|
|
|
QUINOLONES
|
|
|
Ciprofloxacin is effective in a variety of infections due to gram-
positive and gram-negative pathogens, including multi-resistant strains. It is also indicated for us in individuals exposed to inhalational, cutaneous and post exposure anthrax. |
|
|
Gastrointestinal disturbances; CNS side effects, including seizures. Increases in transaminases and in some cases severe and fatal hepatitis have developed. Hematuria and anaphylactic reactions have been described. Fluroquinolones have been associated with an increasd risk of tendonitis and tendon rupture.
|
|
|
Adult: 250-750mg twice daily, depending on the severity of the infection. Inhalational post-exposure anthrax: 500mg every 12 hours. Pediatric: inhalational p ost-exposure anthrax: 10mg/kg every 12 hours. Maximum 400mg daily. See BDS supply protocols
|
|
|
|
|
|
Avoid in pregnancy—shown to cause arthropathy in animal studies; safer alternatives are available.
|
|
|
Amount too small to be harmful but manufacturer advises avoid.
|
|
|
|